IPS Therapeutique
Business Services · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3035 Boul Industriel, Sherbrooke, Quebec...Phone Number
(819) 820-1515Website
www.ipstherapeutique.comRevenue
<$5 MillionIndustry
About IPS Therapeutique
IPS Therapeutique is a Contract Research Organization specializing in preclinical drug development, focusing on efficacy and safety testing for various diseases, including cardiovascular, respiratory, and inflammatory disorders. Established in 1999, the company has conducted over 3,000 preclinical studies and offers bespoke non-clinical drug development services. Their state-of-the-art laboratory in Sherbrooke, Quebec, supports the development of predictive models to address the pharmaceutical industry's translational challenges. IPS Therapeutique aims to assist clients in navigating the complexities of drug development through innovative research and validated models.Explore more
IPS Therapeutique Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to IPS Therapeutique
Compare insights from companies similar to IPS Therapeutique, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
IPS Therapeutique Tech Stack
A closer look at the technologies used by IPS Therapeutique
See more technologies
Top Business Services Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding IPS Therapeutique
Sign Up For FreeTo access detailed company insights
IPS Therapeutique is a Contract Research Organization specializing in preclinical drug development, focusing on efficacy and safety testing for various diseases, including cardiovascular, respiratory, and inflammatory disorders. Established in 1999, the company has conducted over 3,000 preclinical studies and offers bespoke non-clinical drug develo... Read More
